Skip to main content
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Leukemia
Leukemia
,
Oncology
Adherence to Ibrutinib Therapy Improves Outcomes in Patients with CLL
Laura Morgan
Read More
Leukemia
,
Oncology
Brentuximab Cost-Effective After Transplant
Chase Doyle
Read More
Leukemia
,
Oncology
Pediatric Regimen a New Standard for Adolescents and Young Adults with Acute Lymphoblastic Leukemia
Read More
Leukemia
,
Oncology
CAR-T Achieves High Rate of Remission in Pediatric Relapsed/Refractory Acute Lymphoblastic Leukemia
Wayne Kuznar
Read More
Leukemia
,
Oncology
Sorafenib Prolongs Event- and Relapse-Free Survival in Acute Myeloid Leukemia
Read More
Leukemia
,
Oncology
Pracinostat-Azacitidine Combination Generates Responses in Older Adults with Acute Myeloid Leukemia
Wayne Kuznar
Read More
Leukemia
,
Oncology
Psychological Distress and Financial Burden Impact Adherence to CML Treatment
Phoebe Starr
Read More
Leukemia
,
Oncology
Ibrutinib Outperforms Ofatumumab in Patients with Relapsed/Refractory CLL
Caroline Helwick
Read More
Leukemia
,
Oncology
Idelalisib Improves Outcomes in Heavily Pretreated Patients with CLL
Wayne Kuznar
Read More
Leukemia
,
Oncology
Nilotinib Sustains Deeper Molecular Response versus Imatinib in Patients with Ph+ CML
Wayne Kuznar
Read More
2
3
4
5
6
7
Page 5 of 7
Results 41 - 50 of 70